DIGITAL EDITIONS

Tag: Pyoderma Gangrenosum

Consecutive Cases of Pyoderma Gangrenosum Following Dermatologic Surgery

August 1, 2020

J Clin Aesthet Dermatol. 2020;13(8):49–50 by Brian Wanner, DO; Stephanie Saridakis, DO; and Dawn Sammons, DO Dr. Wanner is a dermatology resident, PGY-3, at OhioHealth Riverside Methodist Hospital in Columbus, Ohio. Dr. Saridakis is an intern, PGY-1, at OhioHealth Riverside Methodist Hospital in Columbus, Ohio. Dr. Sammons is Dermatology Residency Program Director at OhioHealth Riverside

Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab

May 1, 2019

J Clin Aesthet Dermatol. 2019;12(5):28–32 by Raymond E. Kleinfelder, DO; Nady Hin, DO; Stefanie Cubelli, DO; Allan Snyder, PA-C; Francisco Kerdel, BSc, MBBS; and Brad Glick, DO, MPH Drs. Kleinfelder and Hin are with the Dermatology Residency Program at the LECOMT/Larkin Community Hospital, Palm Springs Campus, in Hialeah, Florida. Dr. Cubelli is with St. John’s Episcopal

Pyoderma Gangrenosum-associated Granulomatosis with Polyangitis: A Case Report and Literature Review

October 1, 2017

by Matthew B. Zarraga, DO; Nicole Swenson, DO; and Brad Glick, DO, MPH, FAOCD Dr. Zarraga is the chief dermatology resident at Wellington Regional Medical Center in Wellington, Florida; Dr. Swenson is a research fellow at the Center for Clinical and Cosmetic Research in Aventura, Florida; and Dr. Glick is the program director at Wellington Medical

A Second Case of Sunitinib-associated Pyoderma Gangrenosum

August 5, 2010

Steven M. Dean, DO, FACP, RPVI; Matthew Zirwas, MD The Ohio State University, Columbus, Ohio Disclosure: Drs. Dean and Zirwas report no relevant conflicts of interest. Abstract Pyoderma gangrenosum is a painful, noninfectious, ulcerative, cutaneous disorder that most commonly affects the lower extremities. The diagnosis is made by recognizing the characteristic clinical manifestations in the

Pyoderma Gangrenosum in a Patient with Bruton’s X-linked Agammaglobulinemia: Shared Pathogenesis of Altered Tumor Necrosis Factor Alpha?

May 9, 2008

by Elissa M. Schwartzfarb, BS, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida; Dot Weir, RN, CWON, CWS, Clinical Director, The Wound Center at Osceola Regional Medical Center, Kissimee, Florida; Walter A. Conlan III, MD, CWS, Medical Director, The Wound Center at Osceola Regional Medical Center, Kissimee, Florida;